Landry Matthew L, Trager Richard, Broccatelli Fabio, Crawford James J
Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
ACS Med Chem Lett. 2022 Mar 11;13(4):727-733. doi: 10.1021/acsmedchemlett.2c00071. eCollection 2022 Apr 14.
The metabolic stability of compounds is often assessed at an early stage in drug discovery programs by profiling with hepatic microsomes. Exclusion of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) in these assays provides insight into non-cytochrome P450 (CYP)-mediated metabolism. This report uses a matched molecular pair (MMP) application to assess which chemical substituents are commonly susceptible to non-NADPH-mediated metabolism by microsomes. The analysis found the overall prevalence of metabolism in the absence of NADPH to be low, with esters, amides, aldehydes, and oxetanes being among the most commonly susceptible functional groups. Given that non-CYP enzymes, such as esterases, may be expressed extrahepatically and lead to lower confidence in predicted pharmacokinetic profiles, an awareness of the functional groups that commonly undergo non-NADPH-mediated metabolism-as well as options for their replacement based on experimental MMP data-may help researchers derisk metabolic stability issues at an earlier stage in drug discovery.
在药物发现项目的早期阶段,通常通过用肝微粒体进行分析来评估化合物的代谢稳定性。在这些测定中排除还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH),可以深入了解非细胞色素P450(CYP)介导的代谢。本报告使用匹配分子对(MMP)应用来评估哪些化学取代基通常易受微粒体非NADPH介导的代谢影响。分析发现,在没有NADPH的情况下,代谢的总体发生率较低,酯、酰胺、醛和氧杂环丁烷是最常见的易感官能团。鉴于非CYP酶(如酯酶)可能在肝外表达,并导致对预测的药代动力学概况的信心降低,了解通常经历非NADPH介导代谢的官能团,以及根据实验MMP数据进行替代的选择,可能有助于研究人员在药物发现的早期阶段降低代谢稳定性问题的风险。